UNVERIFIEDSingle SourceRecovryAI Announces FDA Breakthrough Device Designation for Patient-Facing Clinical AIBusiness Wire|3/3/2026
UNVERIFIEDSingle SourceCogent Biosciences (COGT) Advances Bezuclastinib-Sunitinib Combination With Breakthrough Therapy Designation (BTD)Insider Monkey|2/2/2026